QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
OTCMKTS:HAVLF

HAVN Life Sciences (HAVLF) Stock Forecast, Price & News

$0.02
+0.01 (+86.96%)
(As of 09/25/2023 ET)
Compare
Today's Range
$0.02
$0.02
50-Day Range
$0.01
$0.03
52-Week Range
$0.00
$0.11
Volume
433 shs
Average Volume
14,037 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

HAVLF stock logo

About HAVN Life Sciences (OTCMKTS:HAVLF) Stock

HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is headquartered in Richmond, Canada.

HAVLF Price History

HAVLF Stock News Headlines

3 Words and a 3,000% Return
In October 2013, a scientist wrote 3 words on a piece of paper. They were simple words. A fiveyear-old could say them. But these three words could deliver you a 3,000% return in 2023 >>>
HAVN.CN - HAVN Life Sciences Inc.
HAVN Life Sciences Inc (HAVN)
HAVN Life Provides Corporate Update
HAVN Life Sciences Inc. (HAVLF)
3 Words and a 3,000% Return
In October 2013, a scientist wrote 3 words on a piece of paper. They were simple words. A fiveyear-old could say them. But these three words could deliver you a 3,000% return in 2023 >>>
IIROC Trading Halt - HAVN
IIROC Trade Resumption - HAVN
HAVN Life enters supply agreement with MPB Group
HAVN Life Launches the Brain Evolve Series
See More Headlines
Receive HAVLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HAVN Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

HAVLF Company Calendar

Today
9/25/2023
Next Earnings (Estimated)
10/02/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:HAVLF
CIK
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Tim Moore (Age 64)
    Interim CFO, CEO & Chairman
    Comp: $128.54k
  • Ms. Jenna Pozar
    Chief Operations Officer
  • Mr. Paul More
    Controller













HAVLF Stock - Frequently Asked Questions

How have HAVLF shares performed in 2023?

HAVN Life Sciences' stock was trading at $0.0595 at the beginning of 2023. Since then, HAVLF stock has decreased by 63.9% and is now trading at $0.0215.
View the best growth stocks for 2023 here
.

Are investors shorting HAVN Life Sciences?

HAVN Life Sciences saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 7,900 shares, an increase of 7,800.0% from the August 15th total of 100 shares. Based on an average daily trading volume, of 8,800 shares, the short-interest ratio is presently 0.9 days.
View HAVN Life Sciences' Short Interest
.

When is HAVN Life Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, October 2nd 2023.
View our HAVLF earnings forecast
.

When did HAVN Life Sciences' stock split?

HAVN Life Sciences's stock reverse split before market open on Wednesday, August 3rd 2022. The 1-30 reverse split was announced on Wednesday, August 3rd 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, August 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

What is HAVN Life Sciences' stock symbol?

HAVN Life Sciences trades on the OTCMKTS under the ticker symbol "HAVLF."

How do I buy shares of HAVN Life Sciences?

Shares of HAVLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is HAVN Life Sciences' stock price today?

One share of HAVLF stock can currently be purchased for approximately $0.02.

This page (OTCMKTS:HAVLF) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -